5 results for author:"Lezcano E." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1). Somme J.H., Gomez-Esteban J.C., Molano A., Tijero B., Lezcano E., Zarranz J.J. J. Neurol. Sci. 310:86-89(2011) · Mapped (7) |
| Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Mata I.F., Hutter C.M., Gonzalez-Fernandez M.C., de Pancorbo M.M., Lezcano E., Huerta C., Blazquez M., Ribacoba R., Guisasola L.M., Salvador C. et al. Neurogenetics 10:347-353(2009) · Mapped (4) |
| Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. Gonzalez-Fernandez M.C., Lezcano E., Ross O.A., Gomez-Esteban J.C., Gomez-Busto F., Velasco F., Alvarez-Alvarez M., Rodriguez-Martinez M.B., Ciordia R., Zarranz J.J. et al. Parkinsonism Relat. Disord. 13:509-515(2007) · Mapped (4) |
| A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Zarranz J.J., Ferrer I., Lezcano E., Forcadas M.I., Eizaguirre B., Atares B., Puig B., Gomez-Esteban J.C., Fernandez-Maiztegui C., Rouco I. et al. Neurology 64:1578-1585(2005) · UniProtKB (1) |
| The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B. et al. Ann. Neurol. 55:164-173(2004) · UniProtKB (1) |